51
|
Erk S, Meyer-Lindenberg A, Linden DE, Lancaster T, Mohnke S, Grimm O, Degenhardt F, Holmans P, Pocklington A, Schmierer P, Haddad L, Mühleisen TW, Mattheisen M, Witt SH, Romanczuk-Seiferth N, Tost H, Schott BH, Cichon S, Nöthen MM, Rietschel M, Heinz A, Walter H. Replication of brain function effects of a genome-wide supported psychiatric risk variant in the CACNA1C gene and new multi-locus effects. Neuroimage 2014; 94:147-154. [DOI: 10.1016/j.neuroimage.2014.03.007] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2013] [Revised: 02/09/2014] [Accepted: 03/09/2014] [Indexed: 12/12/2022] Open
|
52
|
Schott BH, Assmann A, Schmierer P, Soch J, Erk S, Garbusow M, Mohnke S, Pöhland L, Romanczuk-Seiferth N, Barman A, Wüstenberg T, Haddad L, Grimm O, Witt S, Richter S, Klein M, Schütze H, Mühleisen TW, Cichon S, Rietschel M, Noethen MM, Tost H, Gundelfinger ED, Düzel E, Heinz A, Meyer-Lindenberg A, Seidenbecher CI, Walter H. Epistatic interaction of genetic depression risk variants in the human subgenual cingulate cortex during memory encoding. Transl Psychiatry 2014; 4:e372. [PMID: 24643163 PMCID: PMC3966038 DOI: 10.1038/tp.2014.10] [Citation(s) in RCA: 42] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/13/2013] [Accepted: 01/06/2014] [Indexed: 12/14/2022] Open
Abstract
Recent genome-wide association studies have pointed to single-nucleotide polymorphisms (SNPs) in genes encoding the neuronal calcium channel CaV1.2 (CACNA1C; rs1006737) and the presynaptic active zone protein Piccolo (PCLO; rs2522833) as risk factors for affective disorders, particularly major depression. Previous neuroimaging studies of depression-related endophenotypes have highlighted the role of the subgenual cingulate cortex (CG25) in negative mood and depressive psychopathology. Here, we aimed to assess how recently associated PCLO and CACNA1C depression risk alleles jointly affect memory-related CG25 activity as an intermediate phenotype in clinically healthy humans. To investigate the combined effects of rs1006737 and rs2522833 on the CG25 response, we conducted three functional magnetic resonance imaging studies of episodic memory formation in three independent cohorts (N=79, 300, 113). An epistatic interaction of PCLO and CACNA1C risk alleles in CG25 during memory encoding was observed in all groups, with carriers of no risk allele and of both risk alleles showing higher CG25 activation during encoding when compared with carriers of only one risk allele. Moreover, PCLO risk allele carriers showed lower memory performance and reduced encoding-related hippocampal activation. In summary, our results point to region-specific epistatic effects of PCLO and CACNA1C risk variants in CG25, potentially related to episodic memory. Our data further suggest that genetic risk factors on the SNP level do not necessarily have additive effects but may show complex interactions. Such epistatic interactions might contribute to the 'missing heritability' of complex phenotypes.
Collapse
Affiliation(s)
- B H Schott
- Department of Psychiatry, Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany,Leibniz Institute for Neurobiology, Magdeburg, Germany,Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany,Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany,Department of Behavioral Neurology, Leibniz-Institut für Neurobiologie, Brenneckestrasse 6, Magdeburg 39118, Germany E-mail:
| | - A Assmann
- Leibniz Institute for Neurobiology, Magdeburg, Germany,Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany
| | - P Schmierer
- Department of Psychiatry, Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany,Berlin School of Mind and Brain, Humboldt University Berlin, Berlin, Germany
| | - J Soch
- Department of Psychiatry, Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany,Leibniz Institute for Neurobiology, Magdeburg, Germany,Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany
| | - S Erk
- Department of Psychiatry, Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany
| | - M Garbusow
- Department of Psychiatry, Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany
| | - S Mohnke
- Department of Psychiatry, Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany
| | - L Pöhland
- Department of Psychiatry, Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany
| | - N Romanczuk-Seiferth
- Department of Psychiatry, Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany
| | - A Barman
- Leibniz Institute for Neurobiology, Magdeburg, Germany
| | - T Wüstenberg
- Department of Psychiatry, Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany
| | - L Haddad
- Central Institute of Mental Health, Mannheim, Germany
| | - O Grimm
- Central Institute of Mental Health, Mannheim, Germany
| | - S Witt
- Central Institute of Mental Health, Mannheim, Germany
| | - S Richter
- Leibniz Institute for Neurobiology, Magdeburg, Germany,University of Salzburg, Salzburg, Austria
| | - M Klein
- Leibniz Institute for Neurobiology, Magdeburg, Germany
| | - H Schütze
- Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany
| | - T W Mühleisen
- University of Bonn, Bonn, Germany,Research Center Jülich, Jülich, Germany
| | - S Cichon
- University of Bonn, Bonn, Germany,Research Center Jülich, Jülich, Germany,University of Basel, Basel, Switzerland
| | - M Rietschel
- Central Institute of Mental Health, Mannheim, Germany
| | | | - H Tost
- Central Institute of Mental Health, Mannheim, Germany
| | - E D Gundelfinger
- Leibniz Institute for Neurobiology, Magdeburg, Germany,Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany,Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany
| | - E Düzel
- Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany,Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany,Helmholtz Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany
| | - A Heinz
- Department of Psychiatry, Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany
| | | | - C I Seidenbecher
- Leibniz Institute for Neurobiology, Magdeburg, Germany,Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany
| | - H Walter
- Department of Psychiatry, Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany,Forschungsbereich Mind and Brain, Klinik für Psychiatrie und Psychotherapie, Campus Mitte, Charité Universitätsmedizin Berlin, Charitéplatz 1, Berlin 10117, Germany. E-mail:
| |
Collapse
|